Logo
x

Search category

Subscribe Now

~$240M

Merck to Acquire Alydia Health for ~$240M on Behalf of its Planned Spinoff of Organon

Merck to Acquire Alydia Health for ~$240M on Behalf of its Planned Spinoff of Organon

  • March 31, 2021
AbbVie Reports the US FDA's Acceptance of NDA for Atogepant as a Preventive Treatment for Migraine

AbbVie Reports the US FDA's Acceptance of NDA for Atogepant as a Preventive Treatment for Migraine

  • March 31, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.